Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results
Go back to Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.81 -0.05 (1.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.86 | 52 Week High | $45.34 | |||
| Open | $3.89 | 52 Week Low | $15.92 | |||
| Day High | $3.91 | P/E | 1.64 | |||
| Day Low | $3.75 | EPS | $2.33 | |||
| Volume | 230,469 | |||||
